Home | About Us | Grants | Resources | News & Events | Community

detail
Home

About Us
arrowMission
arrowHistory & Background
arrowDisclaimer

Grants
arrowGrant Opportunities
arrowGrant Process
arrowASN Co-Grants
arrowAdvisors
arrow2015 Grant Recipient
arrow
2013 Grant Recipient
arrow
Translational Research

Resources
arrowPatient Registries
arrowPartners
arrowMedical Experts
arrowDefinitions
arrowBio Banks

News & Events
arrow2018 MN Conference in Bergamo
arrow
HFE Gene Linked to MN
arrowCureGN Study at Columbia
arrow
Protein Linked to Kidney Failure
arrowNIH Renews NEPTUNE Funding
arrow
Childhood Stress not trigger for MS
arrowLevin succeeds Remuzzi at ISN

arrowSalant receives Hamburger Award
arrowDrug for MS & Alzheimer's
arrowNeurons & Salt
arrowAutoimmune-Allergy Connection
arrowA Cause of Recurrent MN
arrowBlood Test Detects Kidney Rejection
arrow
Genotyping of Risk Alleles
arrowLink to Gene Variants

arrowBlood Test to Detect MN
arrowMN, an Autoimmune Disease
arrowKey Molecule Impacts Mice
arrowLa Jolla Institute
arrowGluten Specific T-cells
arrowHuman Gene Pool
arrowVitamin D & Clinical Outcomes
arrowBovine Serum Albumen
arrow
Variations in HLA-DQA1 & PLA2R1 regions
arrowKlotho and Kidney Disease
arrowLink between MN and Milk (NEJM)

arrowASN News Release
arrowMario Negri News Release

arrowHyper-IgG4 Syndrome News Release
arrowAdvances in Kidney Disease (RSS)
arrowKidney Disease News (RSS)
arrowNew Patents (RSS)
arrowScience Daily (RSS)
arrowUpcoming Events
arrowEvents Archive

Community
arrowLinks
arrowPublic Service Announcement
arrowOutreach




 

Vitamin D and Clinical Outcomes...
ASN: Nephrologists Focus Globally

Philadelphia (November 8, 2011) — This year's meeting of the American Society of Nephrology -- now called Kidney Week instead of Renal Week -- will have a worldwide focus, according to the program chair Mark Okusa, MD.

The theme of the meeting, Okusa told MedPage Today,is global kidney health through research and education. As meeting organizers were selecting the theme, he said, they considered the continuing problems of noncommunicable health issues that directly affect kidney health.

"For instance, obesity and diabetes are basically in epidemic proportion, not only in the United States but in the whole world," Okusa, of the University of Virginia in Charlottesville, said. "And so the focus on global health was very important to us."

One way the organizers will focus attention on certain key issues is through the "meetings within a meeting" approach, grouping together presentations on topics of special interest in the same location and at the same time each day. The program dealing with obesity and diabetes, for example, is dubbed "diabesity."
Two Hot Topics sessions and a Late-Breaking Clinical Trials session will also cover top-of-mind issues for most nephrologists, Okusa said.

In one of the Hot Topics sessions, for instance, attendees will learn about the recent European outbreak of hemolytic-uremic syndrome caused by an E. coli variant and the treatment that was started in response -- the monoclonal antibody eculizumab (Soliris).

The late-breaking clinical trials session will have six presentations, including one on the FISH study -- a randomized trial looking at the use of fish oil to inhibit hemodialysis graft stenosis -- and one looking at whether the use of vitamin D therapy can improve clinical outcomes.

Source: Todd Neale, Senior Staff Writer, MedPage Today